SHIVA GUPTA to Sulfonamides
This is a "connection" page, showing publications SHIVA GUPTA has written about Sulfonamides.
Connection Strength
0.169
-
Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC). Abdom Radiol (NY). 2020 06; 45(6):1872-1882.
Score: 0.092
-
Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy. AJR Am J Roentgenol. 2017 Dec; 209(6):1278-1284.
Score: 0.077